The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Study examines three-day antibiotic regimens for treating bladder infection in women

CHICAGO A three-day regimen of the antibiotic amoxicillin-clavulanate is not as effective as ciprofloxacin at treating an uncomplicated bladder infection in women, according to a study in the February 23 issue of JAMA.

Acute uncomplicated urinary tract infections (UTIs) are among the most commonly encountered bacterial infections in women, according to background information in the article. Management of these infections has been made more complicated in recent years by increasing antimicrobial resistance, which has led to increased use of alternative antibiotics. There have been no published studies on the efficacy of one such antibiotic, amoxicillin-clavulanate, in the treatment of acute cystitis (inflammation of the urinary bladder) in the current era of high-level amoxicillin resistance.

Thomas M. Hooton, M.D., of the University of Washington and Harborview Medical Center, Seattle, and colleagues conducted a randomized trial that compared 3-day regimens of amoxicillin-clavulanate and ciprofloxacin for treatment of women with acute uncomplicated cystitis and used follow-up to evaluate the women for recurrent infection. Ciprofloxacin is in the fluoroquinolone class of antibiotics, a potent and frequently prescribed group that has shown increasing resistance. The trial included 370 women, aged 18 to 45 years. Subjects were randomly assigned to receive amoxicillin-clavulanate (500 mg/125 mg twice daily) or ciprofloxacin (250 mg twice daily) for 3 days and were followed for 4 months.

The researchers found that clinical cure resolution of the symptoms associated with UTI was observed in 93 (58 percent) of 160 women treated with amoxicillin-clavulanate compared with 124 (77 percent) of 162 women treated with ciprofloxacin. Amoxicillin-clavulanate was not as effective as ciprofloxacin even among women infected with bacterial strains susceptible to amoxicillin-clavulanate (65 [60 percent] of 109 women in the amoxicillin-clavulanate group vs. 114
'"/>

Contact: Susan Gregg-Hanson
206-731-4097
JAMA and Archives Journals
22-Feb-2005


Page: 1 2

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
(Date:11/23/2009)...GTON, Va. The Infectious Diseases Society of Amer...ma administration and the European Union to furthe... of 10 new antibiotics within the next 10 years, k... Organization (WHO) has identified antimicrobial r...human health. , A new European Union report conf...
(Date:11/23/2009)... iCRco is proud to announce its par... and received the highest grade possible amongst a...urer to be rated “A” in sales, service...r satisfaction in software functionality. iCRco is...grade by the most prestigious research firm in med...
(Date:11/23/2009)...EXANDRIA,Va.,Nov.23/PRNewswire/--JustintimefortheT...shomechefswithtipsandrecipesforcookingupadelicious...entnewsandhealthinformation, turkeyfrying.net ...dturkeyaswellaspartyideasfortakingtheturkeybeyondT...enticallySouthernwayofdeep-fryingwith100%peanutoil...
(Date:11/23/2009)...s findings support link between mental and physica...News) -- Being depressed might take as many years ...s. , However, a combination of depression and a...t depression. , Researchers came to their concl...of more than 60,000 people. During the four years ...
(Date:11/23/2009)...o store fat on their waist in middle age are more ... get older, reveals a new study from the Sahlgrens...in the scientific journal Neurology . , "Anyone...ater risk of dying prematurely due to a heart atta...urer at the Sahlgrenska Academy. "If they neverthe...
Breaking Medicine News(10 mins):Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 3Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 2Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 3Health News:Depression May Up Death Risk to That of Smoking 2
(Date:11/23/2009)..., LINCOLNSHIRE,Ill.,Nov.23/PRNewswire/--Sarno...althcareproductsintheemergencymedicalservices(EMS)...ntedfourexecutivestoitsseniormanagementteam.Thenew...sales;DonnaHill,executivevicepresidentandgeneralco...;andGregRobitaille,executivevicepresidentofcorpora...
(Date:11/23/2009)..., SOUTHSANFRANCISCO,Calif.,Nov.23/PRNewswire-...cedthatDr.TedW.LoveandDr.DavidC.U,Prichardhaveagre...ionoftheproposedmergerbetweenAnesivaandArcionThera...ervotescheduledtotakeplaceatthepreviouslyannounced...ecember3,2009at9:00a.m.PSTat400OysterPoint,Suite10...
(Date:11/23/2009)..., ALISOVIEJO,Calif.,Nov.23/PRNewswire-FirstCa...maceuticals International(NYSE: VRX ),todayannounc...eandclidiniumbromide,anauthorizedgeneric(AG)versio...andexpectstobeasignificantplayerintheLibrax®g...meanimportantdivisionofourU.S.businesswithitssucce...
Breaking Medicine Technology:Sarnova Expands Senior Management Team 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Oceanside Pharmaceuticals Announces Launch of Librax(R) AG 2Kaiser Permanente Honored for Efforts to Combat Obesity With 2009 Pioneering Innovation Award at Weight of the Nation Conference 53085 1Kaiser Permanente Honored for Efforts to Combat Obesity With 2009 Pioneering Innovation Award at Weight of the Nation Conference 53085 2Kaiser Permanente Honored for Efforts to Combat Obesity With 2009 Pioneering Innovation Award at Weight of the Nation Conference 53085 3Kaiser Permanente Honored for Efforts to Combat Obesity With 2009 Pioneering Innovation Award at Weight of the Nation Conference 53085 4Sharing Miracles Television Program to Feature Four Time World Series Champ Darryl Strawberry 53080 1Sharing Miracles Television Program to Feature Four Time World Series Champ Darryl Strawberry 53080 2Sharing Miracles Television Program to Feature Four Time World Series Champ Darryl Strawberry 53080 3Sharing Miracles Television Program to Feature Four Time World Series Champ Darryl Strawberry 53080 4Sharing Miracles Television Program to Feature Four Time World Series Champ Darryl Strawberry 53080 5Sharing Miracles Television Program to Feature Four Time World Series Champ Darryl Strawberry 53080 6Sharing Miracles Television Program to Feature Four Time World Series Champ Darryl Strawberry 53080 7Smith 26 Nephew Announces Launch of ACTICOAT Flex Wound Care Products in the USA 53076 1Smith 26 Nephew Announces Launch of ACTICOAT Flex Wound Care Products in the USA 53076 2Smith 26 Nephew Announces Launch of ACTICOAT Flex Wound Care Products in the USA 53076 3Smith 26 Nephew Announces Launch of ACTICOAT Flex Wound Care Products in the USA 53076 4
Other News:
... today announced that Neil G. Bluhm, a prominent r...d $10 million to the Northwestern Cardiovascular I...ascular Institute of Northwestern Memorial Hospita...ched in April of 2004 with the arrival of renowned...
...clot-dissolving drugs such as tPA has been found b...o improve a test that identifies potentially deadl...fairly simple concept," says Dr. Vincent J.B. Robi... Affairs Medical Center in Augusta and lead author...
...ses are parasitic diseases which kill several thou...ntries. The effectiveness of existing treatments i...ty and the emergence of resistance. A family of al... therapeutic line to follow. Following on from the...
Several popular plans for the revamping the Social Security system contain clauses that could fail to significantly protect older women, according to research reported in the February 2005 issue of Th
health news:Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program 2health news:Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program 3health news:Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program 4health news:Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program 5health news:Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program 6health news:Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program 7health news:Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program 8health news:Clot-busting drugs may help detect potentially deadly leg clots 2health news:Clot-busting drugs may help detect potentially deadly leg clots 3health news:New highly active agents against sandfly fever 2health news:New highly active agents against sandfly fever 3
...s -- A new Rand Corporation report, Costs and Bene... published in the May 16 issue of the Annals of In...ify the Regenstrief Institute, Inc., of Indianapol...rmation pioneer, as the source of nearly one-fourt...
...a, PA Researchers at the University of Pennsylvan... by which drugs like Celebrex and Vioxx cause hear...s offer the prospect of a new generation of anti-i...ted in the April 13 advanced online edition and Ma...
...ous events of the TGN1412 trial indicate that urge...regulation of phase I trials of biological agents,...ancet.......The UK Medicines and Healthcare produc... first-in-man trial of TeGenero's TGN1412 in which...
...of cyclooxygenase-2 (COX-2) were developed to reli...al anti-inflammatory drugs (NSAIDS), but without o...leeding. However, an unexpected adverse cardiovasc...rction was subsequently detected, causing the hig...
health news:National report identifies Regenstrief Institute as health care information leader 2health news:Therapeutic prospects beyond Vioxx 2health news:Therapeutic prospects beyond Vioxx 3health news:Researchers resolve how COX inhibitors cause heart hazards, and offer alternative treatment strategy 2